XML 34 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Revenue - Schedule of Revenue Recognized in Consolidated Statements of Profit or Loss (Detail) - EUR (€)
€ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenue from external customers    
Commercial sale of products € 31,551 € 1,888
Rendering of services 1,170 372
Sale of clinical supply 254 3,936
"Right-to-use" licenses 614 632
Total revenue 33,589 6,828
Revenue from external customers (geographical)    
Total revenue 33,589 6,828
Goods or services transferred over time [member]    
Revenue from external customers    
Total revenue 1,170 372
Revenue from external customers (geographical)    
Total revenue 1,170 372
Goods or services transferred at point in time [member]    
Revenue from external customers    
Total revenue 32,419 6,456
Revenue from external customers (geographical)    
Total revenue 32,419 6,456
Commercial customers [Member]    
Revenue from external customers    
Total revenue 31,551 1,888
Revenue from external customers (geographical)    
Total revenue 31,551 1,888
Collaboration partners and license agreements [Member]    
Revenue from external customers    
Total revenue 2,038 4,940
Revenue from external customers (geographical)    
Total revenue 2,038 4,940
Europe [Member]    
Revenue from external customers    
Total revenue 0 135
Revenue from external customers (geographical)    
Total revenue 0 135
North America [member]    
Revenue from external customers    
Total revenue 33,070 6,456
Revenue from external customers (geographical)    
Total revenue 33,070 6,456
China [member]    
Revenue from external customers    
Total revenue 519 237
Revenue from external customers (geographical)    
Total revenue € 519 € 237